BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, December 20, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 8, 2000

View Archived Issues

Palladium isotope blocks restenosis in preclinical study

Read More

Phase I trial of TOBI in ventilator-associated pneumonia initiated

Read More

Researchers release genetic structure of the largest bacterium sequenced to date

Read More

Licensing opportunity from NIH: cloned genomes of infectious GB virus B

Read More

Combination approved for second-line treatment of hypertension

Read More

Maxamine granted priority FDA review for melanoma

Read More

Grant to study 5D12 in prevention of transplant rejection awarded to Tanox

Read More

Inosine produces significant recovery of limb function in rat model of stroke

Read More

Genome Therapeutics acquires exclusive access option to antimicrobials

Read More

Waiting period for Chiron-Pathogenesis merger terminated early; regulatory filings complete

Read More

Pherin and Taisho establish vomeropherin collaboration

Read More

Transdermal testosterone improves sexual function after surgical menopause

Read More

J&J to develop novel antidiabetic agent discovered by Tanabe

Read More

Merck's focus on more effective and safe agents for BPH continues

Read More

Merck selects thiazole benzenesulfonamide for further evaluation as potential obesity Rx

Read More

New discoveries in the field of NPY antagonists presented by RWJ at ACS meeting

Read More

Structure of new oral anticoagulant revealed by DuPont at recent congress

Read More

Xolair, a major advance in the treatment of asthma and rhinitis, highlighted at ERS

Read More

Clinical trials begin with CTV-05 for treatment of bacterial vaginosis

Read More

Radiodiagnostic agents for assessing tumor oxygenation status and radioresistance

Read More

New polyazanaphthalenones for BPH

Read More

A series of dual 5-HT1A antagonists and 5-HT reuptake inhibitors described by Lundbeck

Read More

Potential antipsychotics patented by MS&D

Read More

Inhale and Lilly reinitiate development of inhalable Forteo; discontinue other program

Read More

SB's new protein tyrosine kinase inhibitors useful as antibacterial agents

Read More

Yamanouchi discovers naturally occurring cytotoxic depsipeptide

Read More

New ocular hypotensive agents in the Alcon pipeline

Read More

UR-12746, a novel IBD candidate

Read More

Consensus on Statins -- Live Webcast from Paris available September 9

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 19, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 19, 2025.
  • Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

    HIV research is close to a cure but far from ending the pandemic

    BioWorld
    Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing